Table 3.
Summary of 3-month postoperative clinical data in the two groups defined in the current study. The corresponding p-values for the comparison between groups are shown for each parameter evaluated
| Mean (SD) Median (range) |
Eyhance group | Vivinex group | p-value |
|---|---|---|---|
| Monocular LogMAR UDVA |
0.09 (0.13) 0.07 (− 0.14 to 0.50) |
0.10 (0.13) 0.09 (− 0.08 to 0.40) |
0.889 |
| Binocular LogMAR UDVA |
0.01 (0.11) 0.02 (− 0.18 to 0.30) |
0.00 (0.08) − 0.02 (− 0.16 to 0.20) |
0.685 |
| Monocular LogMAR CDVA |
0.00 (0.10) 0.00 (− 0.18 to 0.30) |
− 0.02 (0.11) − 0.04 (− 0.24 to 0.30) |
0.167 |
| Binocular LogMAR CDVA |
− 0.05 (0.09) − 0.05 (− 0.18 to 0.20) |
− 0.08 (0.07) − 0.08 (− 0.24 to 0.10) |
0.752 |
| Monocular LogMAR UIVA |
0.24 (0.15) 0.22 (− 0.06 to 0.66) |
0.32 (0.13) 0.30 (0.06 to 0.64) |
0.001 |
| Binocular LogMAR UIVA |
0.12 (0.11) 0.12 (− 0.10 to 0.44) |
0.22 (0.12) 0.19 (0.00 to 0.48) |
0.001 |
| Monocular LogMAR DCIVA |
0.23 (0.13) 0.22 (− 0.14 to 0.48) |
0.33 (0.12) 0.34 (0.10 to 0.60) |
0.002 |
| Binocular LogMAR DCIVA |
0.12 (0.11) 0.12 (− 0.16 to 0.40) |
0.24 (0.10) 0.24 (0.10 to 0.42) |
< 0.001 |
| Sphere (D) |
0.44 (0.47) 0.50 (− 0.50 to 1.50) |
0.17 (0.45) 0.13 (− 0.75 to 1.25) |
0.002 |
| Cylinder (D) |
− 0.75 (0.48) − 0.75 (− 2.00 to 0.00) |
− 0.58 (0.42) − 0.50 (− 1.75 to 0.00) |
0.019 |
| Spherical equivalent (D) |
0.06 (0.39) 0.00 (− 0.88 to 1.12) |
− 0.12 (0.37) − 0.13 (− 0.88 to 0.75) |
0.006 |
| J0 (D) |
− 0.13 (0.34) − 0.12 (− 0.99 to 0.62) |
− 0.17 (0.27) − 0.14 (− 0.86 to 0.37) |
0.718 |
| J45 (D) |
− 0.02 (0.26) 0.00 (− 0.62 to 0.59) |
0.00 (0.16) 0.00 (− 0.38 to 0.35) |
0.732 |
| B (D) |
0.51 (0.29) 0.53 (0.00 to 1.13) |
0.48 (0.22) 0.45 (0.00 to 0.95) |
0.251 |
SD standard deviation, D diopters, UDVA uncorrected distance visual acuity, UIVA uncorrected intermediate visual acuity, CDVA corrected distance visual acuity, DCIVA distance-corrected intermediate visual acuity, J0 and J45 power vectors, B overall blur strength